Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ENROLLING BY INVITATION
NCT07949747
NA

Evaluating Pulsed Dye Laser Treatment Parameters on Clearance of Vascular Indications

Sponsor: University of California, Irvine

View on ClinicalTrials.gov

Summary

The goal of this prospective clinical study is to evaluate pulsed dye laser treatment parameters on the clearance of vascular indications, including rosacea and port wine capillary malformations. The main question it aims to answer is: \- Does the use of post-cooling, compared with no post-cooling, affect patient-reported pain scores and treatment outcomes after one treatment session? Participants will: * Receive PDL treatment according to the study protocol. * Complete all required follow-up visits and questionnaires. * Undergo OCT imaging assessments, as applicable to the study protocol.

Official title: A Prospective Clinical Study Evaluating Pulsed Dye Laser Treatment Parameters on Clearance of Vascular Indications

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

25

Start Date

2026-07-06

Completion Date

2028-12

Last Updated

2026-11-19

Healthy Volunteers

Yes

Interventions

DEVICE

Laser with DCD Pre- and Post-Cooling

Study subject will undergo informed consent procedure, eligibility screening, and enrollment to receive treatment to one or more treatment areas depending on the presenting condition and principal investigator assessment. Study subject may receive 1-3 treatments within the study with 4-12 weeks between each treatment visit. Two test areas will be determined in the area(s) of the vascular condition. Each lesion will serve as its own control, since it is divided in half and each side receives a different set of laser settings. The following laser settings will be applied: Area 1: Spot size 7-15mm; pulse duration 1.5-10 ms; fluence 5-8 j/cm2; cooling settings 10-30/20-30/10-20 ms

DEVICE

Laser with Standard DCD Pre-Cooling Only

Study subject will undergo informed consent procedure, eligibility screening, and enrollment to receive treatment to one or more treatment areas depending on the presenting condition and principal investigator assessment. Study subject may receive 1-3 treatments within the study with 4-12 weeks between each treatment visit. Two test areas will be determined in the area(s) of the vascular condition. Each lesion will serve as its own control, since it is divided in half and each side receives a different set of laser settings. The following laser settings will be applied: Area 2: Spot size 7-15mm; pulse duration 1.5-10 ms; fluence 5-8 j/cm2; cooling settings 10-30/20-30/0 ms

Locations (1)

University of California, Irvine

Irvine, California, United States